$0.141
-0.0051[-3.49%]
At close: Apr 22
$0.141
0[0.00%]
PreMarket: 7:46PM EDT
Pieris Pharmaceuticals
(NASDAQ:PIRS)Pieris Pharmaceuticals Stock (NASDAQ:PIRS), Quotes and News Summary
Pieris Pharmaceuticals Stock (NASDAQ: PIRS) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 8.228K |
| Day Range | - - - |
| 52 Wk Range | 10.888 - 80.800 |
| Market Cap | $13.950M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 10 |
| Short Interest | 11.03% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Pieris Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the disco...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Pieris Pharmaceuticals (PIRS) stock?
You can purchase shares of Pieris Pharmaceuticals (NASDAQ: PIRS) through any online brokerage.
Who are Pieris Pharmaceuticals's (PIRS) competitors?
Other companies in Pieris Pharmaceuticals’s space includes: Macrogenics (NASDAQ:MGNX), Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA) and Arcutis Biotherapeutics (NASDAQ:ARQT).
What is the target price for Pieris Pharmaceuticals (PIRS) stock?
The latest price target for Pieris Pharmaceuticals (NASDAQ: PIRS) was reported by Baird on Friday, March 13, 2020. The analyst firm set a price target for 5.00 expecting PIRS to rise to within 12 months (a possible 3446.10% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Pieris Pharmaceuticals (PIRS)?
The stock price for Pieris Pharmaceuticals (NASDAQ: PIRS) is $0.141 last updated April 22, 2024 at 7:46 PM EDT.
Does Pieris Pharmaceuticals (PIRS) pay a dividend?
There are no upcoming dividends for Pieris Pharmaceuticals.
When is Pieris Pharmaceuticals (NASDAQ:PIRS) reporting earnings?
Pieris Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
Is Pieris Pharmaceuticals (PIRS) going to split?
There is no upcoming split for Pieris Pharmaceuticals.
What sector and industry does Pieris Pharmaceuticals (PIRS) operate in?
Pieris Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.